Lv2
118 积分 2024-12-24 加入
INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy
23天前
已完结
Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group
23天前
已完结
Feasibility of appropriately extending the surgical interval after neoadjuvant immunotherapy combined with chemotherapy for esophageal squamous cell carcinoma
29天前
已完结
Interval between neoadjuvant chemoradiotherapy and surgery for squamous cell carcinoma of the thoracic esophagus: does delayed surgery have an impact on outcome?
29天前
已完结
Prolonged time to surgery after neoadjuvant chemoradiotherapy increases histopathological response without affecting survival in patients with esophageal or junctional cancer
29天前
已完结
Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial: Standard Versus Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
29天前
已完结
Neoadjuvantchemoimmunotherapy versuschemoradiotherapy foresophageal squamous cellcarcinoma: a multicenter cohortstudy
29天前
已完结
Three-Year Outcomes ofNeoadjuvantChemoimmunotherapy vs.NeoadjuvantChemoradiotherapy inResectable Esophageal Cancer:A Multicenter RetrospectiveStudy
29天前
已完结
Neoadjuvant Chemoradiotherapy vs Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma
29天前
已完结
新辅助化放疗联合手术治疗局部晚期食管鳞状细胞癌的长期疗效:NEOCRTEC5010随机临床试验
29天前
已完结